.Genentech will certainly close its own cancer cells immunology study division, as well as device he...
.Kezar Lifestyle Sciences is actually losing its unpromising phase 1 solid growth medicine as the bi...
.Even with izokibep sustaining its newly found winning streak in the clinic, Acelyrin is actually no...
.Rivus Pharmaceuticals has plumped up the potential customers of its fat-busting, muscle-sparing med...
.Ovid Therapy already showed last month that it was actually trimming back its own headcount as the ...
.Eli Lilly has opened up a $700 million R&D facility in the Boston Seaport, boosting its own RNA ...
.Only five months after securing a $one hundred million IPO, Limitless Bio is already laying off som...
.The first stages of oncology R&D may not be short of appealing new modalities, and also Halda Re...
.Psychopharmacology has drawn three articles about midstage medical trial data analyzing Lykos Thera...
.Avidity Biosciences satisfied financiers with stage 1/2 data in Duchenne muscle dystrophy (DMD) Fri...